The (Con-) Fusion in ALK Diagnostics: When Food and Drug Administration-Approved Algorithms Fail

J Clin Oncol. 2016 Jun 1;34(16):1961-2. doi: 10.1200/JCO.2015.65.4871. Epub 2016 Apr 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Algorithms
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Lung Neoplasms
  • Oncogene Proteins, Fusion
  • Receptor Protein-Tyrosine Kinases
  • United States Food and Drug Administration*

Substances

  • Oncogene Proteins, Fusion
  • Receptor Protein-Tyrosine Kinases